George A. Scangos, Director at Vir Biotechnology, Inc. (VIR), sold 20,112 shares at $9.45 ($190K) on 2025-02-24, disclosed to the SEC on 2025-02-25.
Scheduled sale ($190k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.45 | 10,056 | $95K | 50.0% |
| 2 | $9.45 | 10,056 | $95K | 50.0% |
| Total | $9.45 avg | 20,112 | $190K | 100% |
| Filing → |
| VIR | SELL | 2024-02-20 | $568K | — | Filing → |
| VIR | SELL | 2023-02-24 | $1.4M | — | Filing → |
| VIR | SELL | 2023-02-21 | $1.5M | — | Filing → |